94 related articles for article (PubMed ID: 3157443)
1. Suppressor macrophages in tumor-bearing mice and their selective inhibition by 6-mercaptopurine.
Kataoka T; Oh-hashi F
Cancer Res; 1985 May; 45(5):2139-44. PubMed ID: 3157443
[TBL] [Abstract][Full Text] [Related]
2. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
Kataoka T; Oh-hashi F
Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988
[TBL] [Abstract][Full Text] [Related]
3. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
Kataoka T; Akahori Y; Sakurai Y
Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
[TBL] [Abstract][Full Text] [Related]
4. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
Kataoka T; Oh-hashi F; Sakurai Y; Gomi K
Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
Kataoka T; Yamamoto T; Honjo K; Murayama T
Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
[TBL] [Abstract][Full Text] [Related]
6. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
Raina S; Russo AJ; Jenkins D; Goldrosen MH
Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
[TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of concanavalin A-induced suppressor T cells by 5-fluorouracil.
Kataoka T; Nakamura M; Iwaguchi T
Jpn J Cancer Res; 1985 Oct; 76(10):995-1002. PubMed ID: 2934357
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
Miura T; Maekawa T; Kurashige S; Mitsuhashi S
Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
[TBL] [Abstract][Full Text] [Related]
9. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
10. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice.
Shibata Y; Tamura K; Ishida N
Cancer Res; 1983 Jun; 43(6):2889-96. PubMed ID: 6221795
[TBL] [Abstract][Full Text] [Related]
11. Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors.
Kataoka T; Ogihara K; Sakurai Y
Cancer Res; 1980 Oct; 40(10):3839-45. PubMed ID: 6449286
[TBL] [Abstract][Full Text] [Related]
12. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1983 Jul; 35(7):703-9. PubMed ID: 6194806
[TBL] [Abstract][Full Text] [Related]
13. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.
Robinson MK; Truitt GA; Okayasu T; Wheelock EF
Cancer Res; 1983 Dec; 43(12 Pt 1):5831-6. PubMed ID: 6227383
[TBL] [Abstract][Full Text] [Related]
14. [Modification of suppressor activity and effector activity of tumor-bearing hosts by bleomycin].
Hosokawa M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):677-83. PubMed ID: 2421642
[TBL] [Abstract][Full Text] [Related]
15. Conversion of normal host splenocytes to suppressor cells by tumor-induced suppressor T-cell-derived factor(s): cyclophosphamide treatment reverses inhibitory activity.
Elgert KD; Foo AS; Burger CJ; Farrar WL
J Biol Response Mod; 1983; 2(3):238-50. PubMed ID: 6227709
[TBL] [Abstract][Full Text] [Related]
16. CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma.
Johnson BD; Jing W; Orentas RJ
J Immunother; 2007; 30(2):203-14. PubMed ID: 17471167
[TBL] [Abstract][Full Text] [Related]
17. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
Kataoka T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
[TBL] [Abstract][Full Text] [Related]
18. Environmental conditions favorable for tumor progression in peritoneal cavity induced by peritoneal cells without tumor selectivity.
Segawa K; Ueno Y; Kataoka T
Jpn J Exp Med; 1989 Jun; 59(3):127-33. PubMed ID: 2681889
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
Lee FH; Currie D; Hwang KM
Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
